Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piercarlo Saletti

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Cancer Treatment Reviews|August 29, 2006
Metastatic colorectal cancerPiercarlo Saletti, Franco Cavalli
Journal of Gastrointestinal Oncology|May 15, 2018
Second-line therapy in advanced upper gastrointestinal cancers: current status and new prospectsPiercarlo Saletti, Alberto Zaniboni
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Commentary 2008: 25 or 50 years later?Piercarlo Saletti, Cristiana Sessa, Franco Cavalli
ESMO Open|July 19, 2018
Choosing wisely in oncology: necessity and obstaclesPiercarlo Saletti, Piero Sanna, Luca Gabutti, et al.
Journal of Clinical Medicine|December 23, 2022
Recent and Future Strategies to Overcome Resistance to Targeted Therapies and Immunotherapies in Metastatic Colorectal CancerGiulia Dazio, Samantha Epistolio, Milo Frattini, et al.
BMJ Case Reports|November 20, 2012
The clinical management in familial adenomatous polyposis deserves continuous monitoring for thyroid carcinomaStefano Crippa, Piercarlo Saletti, Jessica Barizzi, et al.
Oncology Letters|June 8, 2017
Neoadjuvant chemotherapy in borderline resectable pancreatic cancer: A case reportMaria Celeste Palmarocchi, Ruben Carlo Balzarotti Canger, Piercarlo Saletti
Tumori|August 20, 2009
Response to oxaliplatin with cetuximab in minor salivary gland adenoid cystic carcinomaSara De Dosso, Luca Mazzucchelli, Michele Ghielmini, et al.
Frontiers in Surgery|March 11, 2026
Emergency rectal cancer: clinical presentation and therapeutic optionsWanda Luisa Rita Petz, Olivier Gié, Rosita Sortino, et al.
Tumori|October 26, 2010
Molecular characterization and response to cetuximab in a patient with refractory squamous cell anal carcinomaSara De Dosso, Vittoria Martin, Elena Zanellato, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Cancer Treatment Reviews|August 29, 2006
Metastatic colorectal cancerPiercarlo Saletti, Franco Cavalli
Journal of Gastrointestinal Oncology|May 15, 2018
Second-line therapy in advanced upper gastrointestinal cancers: current status and new prospectsPiercarlo Saletti, Alberto Zaniboni
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Commentary 2008: 25 or 50 years later?Piercarlo Saletti, Cristiana Sessa, Franco Cavalli
ESMO Open|July 19, 2018
Choosing wisely in oncology: necessity and obstaclesPiercarlo Saletti, Piero Sanna, Luca Gabutti, et al.
Journal of Clinical Medicine|December 23, 2022
Recent and Future Strategies to Overcome Resistance to Targeted Therapies and Immunotherapies in Metastatic Colorectal CancerGiulia Dazio, Samantha Epistolio, Milo Frattini, et al.
BMJ Case Reports|November 20, 2012
The clinical management in familial adenomatous polyposis deserves continuous monitoring for thyroid carcinomaStefano Crippa, Piercarlo Saletti, Jessica Barizzi, et al.
Oncology Letters|June 8, 2017
Neoadjuvant chemotherapy in borderline resectable pancreatic cancer: A case reportMaria Celeste Palmarocchi, Ruben Carlo Balzarotti Canger, Piercarlo Saletti
Tumori|August 20, 2009
Response to oxaliplatin with cetuximab in minor salivary gland adenoid cystic carcinomaSara De Dosso, Luca Mazzucchelli, Michele Ghielmini, et al.
Frontiers in Surgery|March 11, 2026
Emergency rectal cancer: clinical presentation and therapeutic optionsWanda Luisa Rita Petz, Olivier Gié, Rosita Sortino, et al.
Tumori|October 26, 2010
Molecular characterization and response to cetuximab in a patient with refractory squamous cell anal carcinomaSara De Dosso, Vittoria Martin, Elena Zanellato, et al.
Pageof 5